Hycor Acquisition, QPCR Sales Boost Stratagene’s Q3 Revenues

Stratagene on Tuesday reported a 37-percent increase in third-quarter revenues and nearly tripled its quarterly net income.

Stratagene’s revenues increased to $23.1 million for the quarter from $16.9 million in the third quarter of 2003. The company’s Hycor subsidiary, which it acquired in June, was responsible for $5.6 million of the increase in revenues for the quarter, Stratagene said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.